604 related articles for article (PubMed ID: 7693850)
1. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39.
Foy TM; Shepherd DM; Durie FH; Aruffo A; Ledbetter JA; Noelle RJ
J Exp Med; 1993 Nov; 178(5):1567-75. PubMed ID: 7693850
[TBL] [Abstract][Full Text] [Related]
2. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions.
Van den Eertwegh AJ; Noelle RJ; Roy M; Shepherd DM; Aruffo A; Ledbetter JA; Boersma WJ; Claassen E
J Exp Med; 1993 Nov; 178(5):1555-65. PubMed ID: 7693849
[TBL] [Abstract][Full Text] [Related]
3. Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice.
Resetkova E; Kawai K; Enomoto T; Arreaza G; Togun R; Foy TM; Noelle RJ; Volpé R
Thyroid; 1996 Aug; 6(4):267-73. PubMed ID: 8875745
[TBL] [Abstract][Full Text] [Related]
4. An essential role for gp39, the ligand for CD40, in thymic selection.
Foy TM; Page DM; Waldschmidt TJ; Schoneveld A; Laman JD; Masters SR; Tygrett L; Ledbetter JA; Aruffo A; Claassen E; Xu JC; Flavell RA; Oehen S; Hedrick SM; Noelle RJ
J Exp Med; 1995 Nov; 182(5):1377-88. PubMed ID: 7595208
[TBL] [Abstract][Full Text] [Related]
5. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40.
Durie FH; Fava RA; Foy TM; Aruffo A; Ledbetter JA; Noelle RJ
Science; 1993 Sep; 261(5126):1328-30. PubMed ID: 7689748
[TBL] [Abstract][Full Text] [Related]
6. The molecular basis for T cell help in humoral immunity: CD40 and its ligand, gp39.
Marshall LS; Aruffo A; Ledbetter JA; Noelle RJ
J Clin Immunol; 1993 May; 13(3):165-74. PubMed ID: 7686564
[No Abstract] [Full Text] [Related]
7. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory.
Foy TM; Laman JD; Ledbetter JA; Aruffo A; Claassen E; Noelle RJ
J Exp Med; 1994 Jul; 180(1):157-63. PubMed ID: 7516405
[TBL] [Abstract][Full Text] [Related]
8. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis.
Mohan C; Shi Y; Laman JD; Datta SK
J Immunol; 1995 Feb; 154(3):1470-80. PubMed ID: 7529804
[TBL] [Abstract][Full Text] [Related]
9. Diminished expression of CD40 ligand by activated neonatal T cells.
Nonoyama S; Penix LA; Edwards CP; Lewis DB; Ito S; Aruffo A; Wilson CB; Ochs HD
J Clin Invest; 1995 Jan; 95(1):66-75. PubMed ID: 7814647
[TBL] [Abstract][Full Text] [Related]
10. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M
Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
[TBL] [Abstract][Full Text] [Related]
11. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome.
Aruffo A; Farrington M; Hollenbaugh D; Li X; Milatovich A; Nonoyama S; Bajorath J; Grosmaire LS; Stenkamp R; Neubauer M
Cell; 1993 Jan; 72(2):291-300. PubMed ID: 7678782
[TBL] [Abstract][Full Text] [Related]
12. Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease.
Durie FH; Aruffo A; Ledbetter J; Crassi KM; Green WR; Fast LD; Noelle RJ
J Clin Invest; 1994 Sep; 94(3):1333-8. PubMed ID: 7521888
[TBL] [Abstract][Full Text] [Related]
13. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency.
Farrington M; Grosmaire LS; Nonoyama S; Fischer SH; Hollenbaugh D; Ledbetter JA; Noelle RJ; Aruffo A; Ochs HD
Proc Natl Acad Sci U S A; 1994 Feb; 91(3):1099-103. PubMed ID: 7508119
[TBL] [Abstract][Full Text] [Related]
14. The expansive role of CD40 and its ligand, gp39, in immunity.
Foy TM; Durie FH; Noelle RJ
Semin Immunol; 1994 Oct; 6(5):259-66. PubMed ID: 7532456
[TBL] [Abstract][Full Text] [Related]
15. Identification of residues on CD40 and its ligand which are critical for the receptor-ligand interaction.
Bajorath J; Chalupny NJ; Marken JS; Siadak AW; Skonier J; Gordon M; Hollenbaugh D; Noelle RJ; Ochs HD; Aruffo A
Biochemistry; 1995 Feb; 34(6):1833-44. PubMed ID: 7531493
[TBL] [Abstract][Full Text] [Related]
16. In vivo T-B cell interactions and cytokine-production in the spleen.
van den Eertwegh AJ; Laman JD; Noelle RJ; Boersma WJ; Claassen E
Semin Immunol; 1994 Oct; 6(5):327-36. PubMed ID: 7532461
[TBL] [Abstract][Full Text] [Related]
17. In vivo gp39-CD40 interactions occur in the non-follicular compartments of the spleen and are essential for thymus dependent antibody responses and germinal center formation.
van den Eertwegh AJ; Van Meurs M; Foy TM; Noelle RJ; Boersma WJ; Claassen E
Adv Exp Med Biol; 1994; 355():75-80. PubMed ID: 7535976
[No Abstract] [Full Text] [Related]
18. Differential requirements for expression of CD80/86 and CD40 on B cells for T-dependent antibody responses in vivo.
Lumsden JM; Williams JA; Hodes RJ
J Immunol; 2003 Jan; 170(2):781-7. PubMed ID: 12517941
[TBL] [Abstract][Full Text] [Related]
19. The role of CD40 in the regulation of humoral and cell-mediated immunity.
Durie FH; Foy TM; Masters SR; Laman JD; Noelle RJ
Immunol Today; 1994 Sep; 15(9):406-11. PubMed ID: 7524518
[TBL] [Abstract][Full Text] [Related]
20. The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2.
Grabstein KH; Maliszewski CR; Shanebeck K; Sato TA; Spriggs MK; Fanslow WC; Armitage RJ
J Immunol; 1993 Apr; 150(8 Pt 1):3141-7. PubMed ID: 7682232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
